Вы находитесь на странице: 1из 31

Effective Investigations

and
Corrective Actions (CAPA)
P
Proper Investigation
I i i off Quality
Q li E Events

Michael H. Anisfeld
Globepharm Consulting

What Do You Do When The Bad Stuff Happens?

Ignore
I It Pretend It Never Happened

Curse !#&*!$%...
Advise Boss
Advise Your Buddy
Walk Away
It’s a One-Off

Fix It Investigate + Fix

Blame Someone Else Investigate

Investigate, Fix + Document


2

© Copyright, Globepharm Consulting, 2008 1


Failure/Deviation System

The purpose of
Th f a failure/deviation
f il /d i i system is i
to assure that each failure/deviation does not
adversely impact product quality and that
effective corrective action is taken to reduce
the probability of such failure in the future

© Copyright, Globepharm Consulting, 2008 2


Contributors to Failure

Materials
Facilities
Equipment
Instrumentation
People
Processes
Procedures

Failure / Deviation
Definition

F il
Failure
Product does not meet specification.
Failure may be detected in/by
Production
Laboratory

Deviation
Change in procedures, equipment, materials,
personnel related to product manufacture having
an impact on product quality

© Copyright, Globepharm Consulting, 2008 3


Definitions

Immediate Cause
Situation directly causing the problem

Root Cause
Basic Causal Factor, which if corrected or removed prevents a
repeat of the problem

Intermediate Cause
Reason for problem at more fundamental level than the
immediate cause, but not the root cause [why-2, why-3]

Root Cause Analysis


Structured questioning process enabling identification of
underlying beliefs and practices that result in poor quality

Causes of Failure

Common
C mm n Cause
C [End mi – S
[Endemic Systematic]
t m ti ] (Variation)
(V i ti n)
Originates from the basic elements of the process:
Machines
Materials
Methods
Manpower
Measurement

Assignable Cause [Special] (Variation)


An unplanned variation originating outside expected
operating process conditions [special cause variation]

© Copyright, Globepharm Consulting, 2008 4


Failure/Deviations
Measures

There are three key steps in this process and each of these should
be monitored regularly

Recording the failures and deviations


Total number
Number by department

Action on product batch(es) involved


Audit by sampling to verify that corrective action was taken

Corrective action on root causes


There should be an elimination of failures/deviations due to causes
for which corrective actions have been implemented

Regulators Expectations

Comprehensive,
C h i H
Honest A
Approachh To
T
Investigate OOS Results/Failures
Evaluation Using Scientifically Valid Principles
Learning From Experiences
Permanent Solutions To Problem
Authorities Not The Ones To Find The
Problem
10

© Copyright, Globepharm Consulting, 2008 5


11

What to Do
When the Unexpected Happens

UNEXPECTED?
OOS
Laboratory
Manufacturing
Water System
OOT
OOE
OOY
Reconciliation – Yield Check
Reconciliation – Packaging Material

Deviation
Discrepancy
Unusual Event

12

© Copyright, Globepharm Consulting, 2008 6


13

What Do The US Regulations Say?

Investigation
“In ti ti n” specifically
p ifi ll stated
t t d in the
th cGMPs:
GMP :

§211.22 - Responsibilities of quality control unit.


§211.125 - Labeling issuance.
§211.170 - Reserve samples.
§211.180 - General requirements.
§211.186 - Master pproduction and control records.
§211.188 - Batch production and control records.
§211.192 - Production record review.
§211.198 - Complaint files.
§211.204 - Returned drug products.

14

© Copyright, Globepharm Consulting, 2008 7


What Does The EU Guide Say?

“I
“Investigation”
ti ti ” specifically
ifi ll stated
t t d iin th
the GMP
GMPs:

1.3 Quality Assurance


1.4 Quality Control
2.7 Production/QC Responsibilities
5 39 Production
5.39
5.56 Packaging Operations
6.2 Quality Control
8.1 Complaints

15

Future Regulations

An international
i i l harmonized
h i d
approach to

Risk Management

ICH-Q9
16

© Copyright, Globepharm Consulting, 2008 8


ICH-Q9
initiate Risk Management
risk management process

risk assessment
risk identification
nagement tools
s

risk analysis

risk evaluation

risk control unacceptable

risk reduction

risk
i k acceptance
t
Risk man

risk communication OK
risk communication risk acceptance

output/results of the review event


risk management process
17

© Copyright, Globepharm Consulting, 2008 9


CAPA

19

How do you know


what’s happening?

R
Recognize
i that
h there
h is
i a problem:
bl
Capture The Data
Analyze The Data
Trend The Data

Then
hen Fix the problem
problem:
Investigate the Cause
Attempt to Get to “Root Cause”
Implement Effective Fixes
Monitor the Fix

20

© Copyright, Globepharm Consulting, 2008 10


21CFR820.100 - CAPA

§820.100 Corrective and preventive action


(a) Each manufacturer shall establish and maintain procedures
for implementing corrective and preventive action. The
procedures shall include requirements for:
(1) Analyzing processes, work operations, concessions,
quality audit reports, quality records, service records,
complaints, returned product, and other sources of quality
data to identify existing and potential causes of
nonconforming g p
product,, or other quality
q y problems.
p
Appropriate statistical methodology shall be employed
where necessary to detect recurring quality problems;
(2) Investigating the cause of nonconformities relating to
product, processes, and the quality system;
(3) Identifying the action(s) needed to correct and
prevent recurrence of nonconforming product and other
quality problems; 21

21CFR820.100 - CAPA

§820.100 Corrective and preventive action (continued)


(4) Verifying or validating the corrective and preventive action
to ensure that such action is effective and does not adversely
affect the finished device;
(5) Implementing and recording changes in methods and
procedures needed to correct and prevent identified quality
problems;
(6) Ensuring that information related to quality problems or
nonconforming
f mi productd t iis disseminated
di mi t d tot th
those di
directly
tl
responsible for assuring the quality of such product or the
prevention of such problems; and
(7) Submitting relevant information on identified quality
problems, as well as corrective and preventive actions, for
management review.
(b) All activities required under this section, and their results,
shall be documented 22

© Copyright, Globepharm Consulting, 2008 11


CAPA – Analyzing Sources
of Quality Data

Environmental
E i l
Monitoring Process
Complaints/ Deviations
Returns or Failures

Acceptance
Repairs/
Activities
Ser icing
Servicing CAPA
Stability
Calibration/
Data
Maintenance
Audits Yields/Scrap
23

What To Track

T
Track
k By:
B

Product In-process, release, stability, validation

Event Reason for investigation

Operator/Analyst If cause is operator/analyst error

Instrument/Equipment If cause instrument related

Cause Investigation conclusion

Corrective Action Remedy and prevention

Timeliness Time to complete investigations

24

© Copyright, Globepharm Consulting, 2008 12


CAPA Data Collection

Incidents Reported - 2003

Question:
250 Are we Getting Better as a Company?
210 Or Dropping Off in Capturing Incidents?
200 186
178
165 171
150 143
132 130
Incidents 119
100 98 92
85

50

0
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

25

Run Charts: Trend Charts


Environmental Data – Purified Water System

Specification
Upper Limit

OOT? / OOE?

Specification
Lower Limit

26

© Copyright, Globepharm Consulting, 2008 13


Tracking / Trending

Paper/Pen

Spreadsheet (Excel, Oracle)

Dedicated Computer Systems


Trackwise
(Sparta Systems: http://www.sparta-systems.com)
CATSweb
(AssurX: http://www.assurx.com/catsweb.html)
p
MetricStream
(Metric Stream: http://www.metricstream.com)
SmartCAPA
(SmartCAPA: http://www.pilgrimsoftware.com)

Others …..

27

SmartCAPA®
(www.pilgrimsoftware.com)

28

© Copyright, Globepharm Consulting, 2008 14


29

Purpose of Investigation

The
Th purpose off an investigation
i i i iti to
determine the cause of the failure.

Even if the batch is rejected based on the OOS


result, the investigation is necessary to determine
if the result is associated with other batches of
the same drug product or other products

FDA: Draft OOS Guideline, September 1998

30

© Copyright, Globepharm Consulting, 2008 15


Failure / Deviation – What To Do

Failure/Deviation
F il /D i ti Detected
D t t d I f
Inform QA
24 hours

Perform Investigation Batch Disposition

Immediate Fix

30 days
Root Cause Analysis

Communicate to Management

Corrective/Preventive Action

Assess Effectiveness of Fix


31

Investigations:
You’ve Got to Be A Detective!

32

© Copyright, Globepharm Consulting, 2008 16


Investigations 101

P p
Purpose off ann In
Investigation
ti ti n
Obtain facts as to cause
Common
Special - Assignable

Process of an Investigation
Complete
p description
p of problem
p
Validity of inputs
Review key process variables
Determine scope of investigation
Document investigation

33

Learn How To Be A Detective

What Equipment,
Equipment
Machine, Tool?

What Is Wrong?

What Is the
Complaint?

What is the Undesired


Behavior?
34

© Copyright, Globepharm Consulting, 2008 17


Learn How To Be A Detective

Wh is
Who i Involved?
I l d?
Staff
Consultants
Vendors
Visitors

Name names/positions!

35

Learn How To Be A Detective

When does
Wh d the
th problem
bl
occur?
Day
Date
Time
Shift
Phase of operation
When in equipment life
cycle

Are there time patterns?

36

© Copyright, Globepharm Consulting, 2008 18


Learn How To Be A Detective

Whi h
Which:
Unit
Area
Department
Line
Machine

Location of defective
item, or where on
defective item

37

Learn How To Be A Detective

How is the “what”


what or “who”
who
impacted?
Injury / Death
Shut-Down /Start-Up
Damage
Type
Classification of Defects

How Much
How Many
How Big An Issue
What resources are needed
to handle/resolve the issue!

38

© Copyright, Globepharm Consulting, 2008 19


Change Analysis

PROBLEM?
E COMPARISON?

What is the object or What similar object or


process with the problem? process doesn’t have the
WHAT?
problem? What else could be
What is wrong? wrong?
Where does the problem Where else could the
WHERE?
occur problem occur?

When did the problem When did the problem not


WHEN?
happen? happen?

HOW BIG? How large is the problem? How large could it be?

39

Investigation Documentation

A B C D E
40

© Copyright, Globepharm Consulting, 2008 20


Investigation Documentation

Date
D t pproblem
bl m occurredd
Statement of the Problem
Listing of batches impacted
List of personnel interviewed
Statement of each person’s opinions and memory of event
Discussion of potential causes
Discussion of potential impact
Discussion of extent of problem
Recommendations for fixes
Statement of actions taken to fix
Final decisions regarding batch
Management approvals
41

42

© Copyright, Globepharm Consulting, 2008 21


Root Cause Analysis

Corrective
C ti actions
ti tto observations
b ti ((usually
ll symptoms)
t )
have limited effect on sustained improvement or
elimination of recurrence of the failure

Corrective actions need to address the underlying


causes and root causes of a problem in order to
eliminate the situation from recurring

43

Root Cause Analysis

Equipment Management Systems


Design, Capability
Design Qualified Supervision
Maintenance Audits
Operator Error Feedback
Prior Corrective Actions Taken
Procedures Communication
No Procedure Planning
Wrong Procedure Used Process Capability
Procedure Not Available Adequate Time To Perform Task
Procedure Difficult To Use Standards

Training Manpower
None Information Available
When Adequate
Effectiveness Timely
Personnel Problems
Quality Control Training
Inspection Required Fail/Safe Processes
Inspection Performed Environment
Lighting
Noise
Fatigue
44

© Copyright, Globepharm Consulting, 2008 22


Corrective Action

What
Wh is i the
h lowest
l level
l l at which
hi h we
can do something to prevent the
problem from re-occurring?

45

46

© Copyright, Globepharm Consulting, 2008 23


Investigation Tools

Brainstorm
B i t th
the iissues
Flowcharting
Fishbone Analysis – Cause/Effect diagrams
Why-Why Analysis
Pareto Charts
Run Charts
Force Field Analysis
Six-Sigma Analysis - MAIC
Kepner-Tregoe®

47

Brainstorming

Possible
P ibl ttargett questions
ti to
t serve as the th focal
f l point
i t of
f
the brainstorming process:
What would solve the problem?
What strategy could resolve the root cause?
What solutions have already been thought of?
What solutions have not been thought of?
How can we prevent the situation recurring?
What different methods might work?
What crazy ideas might help?

48

© Copyright, Globepharm Consulting, 2008 24


Fishbone Analysis

Manpower Management

People too busy


People not paying attention

Batch
Record
Errors

Methods Machines

49

Why-Why Analysis

Oil Drops
D On
O FlFloor
Dripping Engine
Oil Can to Collect
Funnel in Oil Can
Raise Funnel
Unless you’ve gone
5 levels of questions
you probably have
not got to root cause!
50

© Copyright, Globepharm Consulting, 2008 25


Pareto Analysis

Pareto: 80 – 20 rule
Batch Record Problems
90 87

80

70

60

50

40

30
23
20 18
12
10

0
Signatures Data Errors Other
51

Process Shift, F-440 Particle Size

© Copyright, Globepharm Consulting, 2008 26


APR – Annual Product Review

53

Force-Field Analysis

Th Positive/Negative
The P iti /N ti What
Wh t would
ld make
k What
Wh t would
ld make
k
Analysis for Solutions the problem the problem
can stimulate thinking better? worse?
just as a the force-field
1. 1.
format did in the past.
Since we are looking for 2. 2.
solutions, the two 3. 3.
columns play “better”
better 4. 4.
against “worse”. 5. 5.
6. 6.
7. 7.
8. 8.

54

© Copyright, Globepharm Consulting, 2008 27


Six Sigma Problem Solving – MAIC
Measure A nalyze Improve Control
(1) Describe the (4) Identify Potential (5) Analyze (9) Determine Best Solution (12) Implement
Problem Causes Existing Data Solution
0.251
0 251

IS IS NOT
0.250
Control Plan
What Item
(2) Lid
Function
Prevents Spills
Failure Mode
Lid falls off due
to looseness
Causes
Lid diameter
too large
Effects Control
Burn Go-no go gauge

0.249 Body diameter Burn Go-no go gauge


to small

Where Leaks from drinking hole


Surfaces too slick

Hole too large


Burn

Stain
Sampling Plan

Pin gauge

Hole has too Stain


0.248 direct of path
T M B T M B T M B T M B

When 1 2 3 4 (10) Pilot Solution


Spill when removing lid Lid diameter
too small

Body diameter
to large
Burn

Burn
(above)

(above)

Material catches Burn Sampling Plan

Extent
(6) Construct List of (7) Compare
Verified Facts Causes to Facts
(2) Determine When
Problem Started FACTS

Fact 3
Fact 4
Fact 5
Fact 1
Fact 2
(1) All Machines
19
(2) Second Shift (11) Verify Solution Works
Cause 1 O X X O A
(3) Certain Codes Cause 2 X O A AO
12.5 LSL USL
(4) Started 8/22 Cause 3 O
C O AA O
6
(5) Steadily Worse Cause 4 X A X O O
Jan '87 Jul '87 Jan '88 Jul '88 (6) All Operators Cause 5 O O OO X
Month

15 20 25 30 35
(8) Collect Additional Data
Seal Strength
(3) Measure Problem Until Root Cause Identified
Magnitude OC Curve
10.2 1.0
70 Upper Control Limit
K = 20
T
Number

60
10.0
O
R 50
Radius Pa 0.5
Q K = -20 9.8 Lower Control Limit
40
U
A B C D E F G H E 30
9.6
0.0
1 5 10 15 20 0 2 4 6 8 10
Code 36.0 37.0 38.0

55
L Percent Defective
Subgroup
© Copyright 2000, Taylor Enterprises Inc.

56

© Copyright, Globepharm Consulting, 2008 28


ICH-Q9
initiate Risk Management
risk management process

risk assessment
risk identification
nagement tools
s

risk analysis

risk evaluation

risk control unacceptable

risk reduction

risk
i k acceptance
t
Risk man

risk communication OK
risk communication risk acceptance

output/results of the review event


risk management process
57

Tools To Prioritize
Fixes and Efforts

FME
FMEA - Failure
F il M
Mode
d Eff
Effect Analysis
l i

FTA - Fault Tree Analysis

HACCP - Hazard Analysis,


Analysis
Critical Control Points

58

© Copyright, Globepharm Consulting, 2008 29


Bibliography
Root Cause Analysis:
- Kepner and Tregoe, “The New Rational Manager”
- Paradies and Unger, “Taproot: The System for Root Cause Analysis,
Problem Investigation & Proactive Improvement”
- Ammerman,
Ammerman “TheThe Root Cause Analysis Handbook”
Handbook
- Pokras, “Systematic Problem-Solving and Decision-Making”
Risk:
McDermott et al., “The Basics of FMEA”
Human Error:
Lorenzo, ABS Consulting, “A Manager’s Guide to Reducing Human Error”
g
Management’s Role:
Harbour and Kieffer, “Managing the Quality System”
FDA:
“Investigating Out of Specification (OOS) Test Results for
Pharmaceutical Production” (Guidance), September 1998
Quality Systems Approach to Pharmaceutical GMPs, September 2004

59

Stay In Touch

Michael
Mi h l HH. Ani
Anisfeld
f ld
Globepharm Consulting
313 Pine Street
Deerfield IL 60015, USA

Phone: USA +1+847 914 0922


Fax: USA +1+847 914 0988
E-mail: manisfeld@globepharm.org
Website: www.globepharm.org

60

© Copyright, Globepharm Consulting, 2008 30


61

Questions?

62

© Copyright, Globepharm Consulting, 2008 31

Вам также может понравиться